Overview
Also known as:
Clinical phenotype terms— hover any for plain English:
FDA & Trial Timeline
10 eventsUniversity of Zurich
Rennes University Hospital — NA
City of Hope Medical Center
Ostergotland County Council, Sweden — NA
Ain Shams University
Necmettin Erbakan University
IRCCS SYNLAB SDN
National Taiwan University Hospital — NA
National Taiwan University Hospital — NA
Nanjing First Hospital, Nanjing Medical University
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Persistent hyperplastic primary vitreous.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Persistent hyperplastic primary vitreous at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Persistent hyperplastic primary vitreous.
Community
No community posts yet. Be the first to share your experience with Persistent hyperplastic primary vitreous.
Start the conversation →Latest news about Persistent hyperplastic primary vitreous
Disease timeline:
New recruiting trial: Investigating Predictive Factors of Diabetes Occurence After Duodenalpancreatectomy
A new clinical trial is recruiting patients for Persistent hyperplastic primary vitreous
New recruiting trial: Liquid Biopsy for Early Detection of Colorectal Cancer Using Circular RNA
A new clinical trial is recruiting patients for Persistent hyperplastic primary vitreous
New recruiting trial: lncRNAs as a Biomarker to Assess the Therapeutic Impact of Oral Absorbent ± Probiotics in CKD Patients With PAD
A new clinical trial is recruiting patients for Persistent hyperplastic primary vitreous
New recruiting trial: The Effects of Diet on Small Non-coding RNA I Sperm Cells and the Possible Effects on Reproductive Success: Diet Intervention Effects on Sperm
A new clinical trial is recruiting patients for Persistent hyperplastic primary vitreous
New recruiting trial: "Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients"
A new clinical trial is recruiting patients for Persistent hyperplastic primary vitreous
New recruiting trial: Circulating Non-coding RNA in Acute Ischemic Stroke with Endovascular Treatment (EVTRNA)
A new clinical trial is recruiting patients for Persistent hyperplastic primary vitreous
New recruiting trial: Oral Absorbent and Probiotics in CKD Patients With PAD on Gut Microbiota, IncRNA, Metabolome, and Vascular Function
A new clinical trial is recruiting patients for Persistent hyperplastic primary vitreous
New recruiting trial: Circulating Non-coding RNA in Acute Ischemic Stroke (AISRNA)
A new clinical trial is recruiting patients for Persistent hyperplastic primary vitreous
New recruiting trial: Childhood B-acute Lymphoblastic Leukaemia and Role of CD9 Gene Regulation in Relapse
A new clinical trial is recruiting patients for Persistent hyperplastic primary vitreous
New recruiting trial: Observational Study Analysing the Transcriptome and Mutational Status of Thyroid Carcinomas of Follicular Origin with Different Degrees of Malignancy
A new clinical trial is recruiting patients for Persistent hyperplastic primary vitreous
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Persistent hyperplastic primary vitreous
Which specialists treat Persistent hyperplastic primary vitreous?
17 specialists and care centers treating Persistent hyperplastic primary vitreous are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.